TURKEY’S STRATEGY TOWARDS AFGHANISTAN: SECURITY AND DEVELOPMENT ASSISTANCE

by A. I. Aliyeva
Published 2016-04-01

Raise of short-stemmed vaviloid branched spike lines and their cytogenetics

by A. J. Aliyeva, S. P. Mehdiyeva, R. K. Kerimova
Published 2015-07-01

THE IRON METABOLISM IN CHILDREN IS NORMAL ALSO AT INFECTIOUS DISEASES

by A. M. Aliyeva, L. S. Namazova-Baranova, Т. V. Kazyukova, V. M. Studenikin
Published 2017-03-01

CLINICAL VALUE OF BLOOD BIOMARKERS IN PATIENTS WITH CHRONIC HEART FAILURE

by A. M. Aliyeva, E. V. Reznik, E. T. Hasanova, I. V. Zhbanov, I. G. Nikitin
Published 2018-10-01

Galactin-3: diagnostic and prognostic value in patients with chronic heart failure

by A M Aliyeva, I E Baykova, V A Kislyakov, E T Gasanova, I I Almazova, T V Pinchuk, Yu N Fedulayev, I V Zhbanov, V A Perevertov, I V Kovtyukh, I G Nikitin, E V Reznik
Published 2019-09-01

Markers of vascular damage depending on the blood pressure level: data of the population study ESSE-RF

by A. M. Erina, M. A. Boyarinova, E. V. Moguchaya, E. P. Kolesova, A. S. Aliyeva, O. P. Rotar, E. I. Baranova, S. A. Shalnova, A. D. Deev, Z. T. Astakhova, L. Z. Bolieva, G. V. Tolparov, V. S. Kaveshnikov, V. N. Serebryakova, I. A. Trubacheva, R. S. Karpov, A. Yu. Efanov, M. A. Storozhok, I. V. Medvedeva, S. V. Shalaev, A. N. Rogoza, A. O. Konradi, S. A. Boytsov, E. V. Shlyakhto
Published 2020-07-01

Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology,...

by G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
Published 2019-05-01

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS)

by M. V. Yezhov, S. A. Bliznyuk, N. A. Tmoyan, T. A. Rozhkova, D. V. Duplyakov, V. A. Salchenko, M. A. Kachkovsky, I. I. Shaposhnik, V. V. Genkel, V. S. Gurevich, S. А. Urazgildeeva, A. V. Tregubov, M. V. Muzalevskaya, S. S. Bazhan, O. V. Timoshchenko, I. A. Urvantseva, K. G. Kozhokar, A. A. Sokolov, V. V. Tishko, O. I. Boyeva, E. V. Bolotova, A. M. Namitokov, Yu. B. Kushnaryova, T. Yu. Kuznetsova, V. A. Korneva, D. Yu. Bogdanov, E. E. Chichina, V. M. Solovyov, A. I. Ershova, A. N. Meshkov, V. I. Makogonenko, A. S. Galyavich, D. I. Sadykova, B. V. Pomogaybo, O. L. Barbarash, V. V. Kashtalap, E. A. Shutemova, I. G. Isaeva, R. A. Khokhlov, V. E. Oleynikov, I. V. Avdeeva, V. V. Malakhov, U. V. Chubykina, V. O. Konstantinov, A. S. Aliyeva, V. V. Ovsyannikova, G. I. Furmenko, T. M. Chernykh, O. E. Abashina, A. R. Dzhanibekova, E. S. Slastnikova, L. F. Galimova, P. D. Duplyakova, M. I. Voyevoda
Published 2019-06-01